News|Articles|October 14, 2026

FAQ: West Nile Virus

After 2 adults died of West Nile virus in central North Carolina this month, this FAQ explains how the mosquito-borne virus spreads, who faces the greatest risk of severe neuroinvasive disease, and how clinicians can diagnose, manage, and help prevent infection when no vaccine or antiviral treatment exists.

West Nile virus is the leading cause of mosquito-borne disease in the contiguous United States, causing an average of about 2,000 reported cases a year, including about 1,200 neuroinvasive cases and roughly 120 deaths.1,2 Most people infected never feel sick, but in a small share of patients, mostly older adults and people who are immunocompromised, the virus invades the central nervous system and can cause meningitis, encephalitis, or paralysis. There is no antiviral therapy and no human vaccine, so recognizing the disease and preventing mosquito bites remain the main tools clinicians and the public have.3,4

Related to this article

FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
Following World Rabies Day and a CDC health advisory on a 17% rise in exposure-related calls, Rodney E. Rohde, PhD, explains what the increase means, what people should do when they have an animal bite or scratch, and how clinicians should assess risk and administer post-exposure prophylaxis (PEP).
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.